Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Rang in aandelen #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Aandeelprijs
$0.0009
Laatst gesynchroniseerd: 2025-05-27
Marktkapitalisatie
$1.15K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Arch Therapeutics, Inc. (ARTH)

Categorie

Koersgeschiedenis voor Arch Therapeutics, Inc. (ARTH)
Hoogste slotkoers: $0.00 op 2025-05-01

Laagste slotkoers: $3.67K op 2012-12-01
Koersgeschiedenis van Arch Therapeutics, Inc. van 2012 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2025 -99.61%
2024 -97.03%
2023 -5.00%
2022 -64.68%
2021 -28.45%
2020 -99.69%
2019 -51.23%
2018 -17.82%
2017 1.40%
2016 175.64%
2015 5.30%
2014 -2.69%
2013 131.37%
2012 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR